Keynote comment: Radiotherapy in the age of molecular oncology

被引：8

作者：

Baumann, Michael

机构：

[1] Dresden Univ Technol, Med Fac Carl Gustav Carus, Dept Radiat Oncol, D-01307 Dresden, Germany

[2] Dresden Univ Technol, Med Fac Carl Gustav Carus, OncoRay Ctr Radiat Res Oncol, D-01307 Dresden, Germany

来源：

LANCET ONCOLOGY | 2006年 / 7卷 / 10期

关键词：

D O I：

10.1016/S1470-2045(06)70871-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：786 / 787

页数：2

共 8 条

[1] Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? [J].

Andreassen, CN .

ACTA ONCOLOGICA, 2005, 44 (08) :801-815

[2] Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results [J].

Baumann, M ;

Krause, M .

RADIOTHERAPY AND ONCOLOGY, 2004, 72 (03) :257-266

[3] Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project [J].

Bentzen, SM ;

Heeren, G ;

Cottier, B ;

Slotman, B ;

Glimelius, B ;

Lievens, Y ;

van den Bogaert, W .

RADIOTHERAPY AND ONCOLOGY, 2005, 75 (03) :355-365

[4] Theragnostic imaging for radiation oncology: dose-painting by numbers [J].

Bentzen, SM .

LANCET ONCOLOGY, 2005, 6 (02) :112-117

[5] Timeline - Radiation oncology: a century of achievements [J].

Bernier, J ;

Hall, EJ ;

Giaccia, A .

NATURE REVIEWS CANCER, 2004, 4 (09) :737-U15

[6] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[7] Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy [J].

Krause, Mechthild ;

Zips, Daniel ;

Thames, Howard D. ;

Kummermehr, Johann ;

Baumann, Michael .

RADIOTHERAPY AND ONCOLOGY, 2006, 80 (02) :112-122

[8] Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial [J].

Overgaard, J ;

Hansen, HS ;

Specht, L ;

Overgaard, M ;

Grau, C ;

Andersen, E ;

Bentzen, J ;

Bastholt, L ;

Hansen, O ;

Johansen, J ;

Andersen, L ;

Evensen, JF .

LANCET, 2003, 362 (9388) :933-940

← 1 →